HOME PRODUCTS SERVICES COMPANY CONTACT FAQ

CVACE protocol

Subscribe to New Research on CVACE protocol

chemotherapy protocol consisting of above compounds; used in the treatment of small cell carcinoma of lung & neuroblastoma

Also Known As:

COPE protocol; N6 protocol

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Therapeutics: 15318
- Drug Therapy: 178671
  - Combination Drug Therapy: 9625
    - Antineoplastic Combined Chemotherapy Protocols: 23
      - CVACE protocol: 2
  - Antineoplastic Protocols: 26
    - Antineoplastic Combined Chemotherapy Protocols: 23
      - CVACE protocol: 2
- Clinical Protocols
  - Antineoplastic Protocols: 26
    - Antineoplastic Combined Chemotherapy Protocols: 23
      - CVACE protocol: 2
Inorganic Chemicals: 9
Organic Chemicals: 58
- Hydrocarbons: 412
  - Halogenated Hydrocarbons: 31
    - Mustard Compounds: 2
      - Nitrogen Mustard Compounds: 1
        Phosphoramide Mustards: 4
        Cyclophosphamide: 18416
        CVACE protocol: 2
  - Cyclic Hydrocarbons: 3
    - Aromatic Hydrocarbons: 132
      - Aromatic Polycyclic Hydrocarbons: 831
        Naphthalenes: 9
        Tetrahydronaphthalenes: 1
        Podophyllotoxin: 391
        Etoposide: 8030
        CVACE protocol: 2
        Naphthacenes
        Anthracyclines: 2011
        Daunorubicin: 1964
        Doxorubicin: 20907
        CVACE protocol: 2
- Organophosphorus Compounds: 163
  - Phosphoramide Mustards: 4
    - Cyclophosphamide: 18416
      - CVACE protocol: 2
Polycyclic Compounds: 56
- Aromatic Polycyclic Hydrocarbons: 831
  - Naphthalenes: 9
    - Tetrahydronaphthalenes: 1
      - Podophyllotoxin: 391
        Etoposide: 8030
        CVACE protocol: 2
  - Naphthacenes
    - Anthracyclines: 2011
      - Daunorubicin: 1964
        Doxorubicin: 20907
        CVACE protocol: 2
Carbohydrates: 4088
- Glycosides: 547
  - Aminoglycosides: 1446
    - Anthracyclines: 2011
      - Daunorubicin: 1964
        Doxorubicin: 20907
        CVACE protocol: 2
  - Glucosides: 155
    - Etoposide: 8030
      - CVACE protocol: 2
Heterocyclic Compounds: 60
- Alkaloids: 1065
  - Indole Alkaloids: 36
    - Secologanin Tryptamine Alkaloids: 55
      - Vinca Alkaloids: 337
        Vincristine: 6828
        CVACE protocol: 2
- 2-Ring Heterocyclic Compounds
  - Indoles: 95
    - Indole Alkaloids: 36
      - Secologanin Tryptamine Alkaloids: 55
        Vinca Alkaloids: 337
        Vincristine: 6828
        CVACE protocol: 2

Experts

1.	Keeling, Sally: 1 article (01/2006)
2.	Roud, Helen: 1 article (01/2006)
3.	Sainsbury, Richard: 1 article (01/2006)
4.	LaQuaglia, M: 1 article (01/2001)
5.	Cheung, I Y: 1 article (01/2001)
6.	Heller, G: 1 article (01/2001)
7.	Gerald, W: 1 article (01/2001)
8.	Kramer, K: 1 article (01/2001)
9.	Gollamudi, S: 1 article (01/2001)
10.	Mora, J: 1 article (01/2001)

Related Diseases

1.	Neuroblastoma 01/01/2001 - "The N7 protocol for poor-risk neuroblastoma uses dose-intensive chemotherapy (as in N6 protocol [Kushner et al.: J Clin Oncol 12:2607-2613, 1994] but with lower dosing of vincristine) for induction, surgical resection and 2100 cGy hyperfractionated radiotherapy for local control, and for consolidation, targeted radioimmunotherapy with 131I-labeled anti-GD2 3F8 monoclonal antibody and immunotherapy with unlabeled/unmodified 3F8 (400 mg/m2). "
2.	Dementia (Dementias) 01/01/2006 - "To assess the utility and acceptability of the CI with health practitioners and informal carers of people with dementia, following the European COPE protocol. "

Related Drugs and Biologics

1.	Vincristine (Oncovin)

Related Therapies and Procedures

1.	Radioimmunotherapy
2.	Radiotherapy
3.	Immunotherapy
4.	Drug Therapy (Chemotherapy)